Early-Onset Neonatal Infection and Cerebral Palsy
Clinical Scorecard: Neonatal Infections in Early Life and Their Association with Cerebral Palsy
At a Glance
Category Detail
Condition Key Mechanisms Nonprogressive interference, lesion, or abnormality of the developing brain due to early-life infections. [Source needed] Target Population Near-term and full-term children born in Denmark from 2004 to 2022. Care Setting Registry-based cohort study.
Key Highlights
CP prevalence estimated at 2 to 3 per 1000 children. [Source needed] Early-onset infections include sepsis and meningitis, primarily caused by Group B Streptococcus and Escherichia coli. [Source needed] Most early-onset infections diagnosed clinically without pathogen identification. [Source needed] Increased risk of CP associated with early-onset infections. [Source needed] Study approved by Central Denmark Region and Statistics Denmark. Guideline-Based Recommendations
Diagnosis
Early-onset infection defined as invasive bacterial infection within the first week after birth. [Source needed] CP diagnosed via Danish Cerebral Palsy Registry or Follow-up Program. [Source needed] Management
Children with suspected infections should receive at least 5 days of intravenous antibiotics. [Source needed] Monitoring & Follow-up
Follow-up until July 1, 2025, for children born during the study period. [Source needed] Risks
Increased risk of neurological disorders, including CP, associated with early-onset infections. [Source needed] Patient & Prescribing Data
Liveborn singleton births with at least 35 completed gestational weeks.
Invasive infections require prompt diagnosis and treatment to mitigate risks. [Source needed]
Clinical Best Practices
Utilize validated databases for accurate CP diagnosis. [Source needed] Consider potential confounders in analyses, including birth characteristics and maternal factors. [Source needed] Related Resources & Content
